Wall Street analysts expect Marchex, Inc. (NASDAQ:MCHX) to post sales of $19.71 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Marchex’s earnings, with the lowest sales estimate coming in at $19.62 million and the highest estimate coming in at $19.80 million. Marchex reported sales of $22.05 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 10.6%. The firm is scheduled to issue its next earnings report on Thursday, November 1st.

According to Zacks, analysts expect that Marchex will report full-year sales of $81.67 million for the current year, with estimates ranging from $81.65 million to $81.70 million. For the next year, analysts forecast that the business will post sales of $82.52 million per share, with estimates ranging from $81.14 million to $83.90 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that cover Marchex.

Marchex (NASDAQ:MCHX) last released its quarterly earnings data on Wednesday, August 1st. The technology company reported ($0.03) EPS for the quarter. Marchex had a negative net margin of 3.35% and a negative return on equity of 3.44%. The firm had revenue of $20.22 million during the quarter, compared to the consensus estimate of $19.60 million.

Separately, Northland Securities began coverage on shares of Marchex in a research report on Tuesday, June 12th. They issued an “outperform” rating for the company.

MCHX opened at $2.89 on Tuesday. Marchex has a 12 month low of $2.52 and a 12 month high of $3.67. The firm has a market capitalization of $123.26 million, a P/E ratio of -20.64 and a beta of 1.29.

In other news, major shareholder Edenbrook Capital, Llc acquired 15,966 shares of the stock in a transaction that occurred on Friday, September 14th. The stock was acquired at an average price of $2.69 per share, for a total transaction of $42,948.54. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. In the last 90 days, insiders purchased 20,866 shares of company stock valued at $56,339. 22.49% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its stake in Marchex by 8.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,769,937 shares of the technology company’s stock worth $5,416,000 after purchasing an additional 131,797 shares during the period. Renaissance Technologies LLC boosted its stake in Marchex by 2.3% in the 2nd quarter. Renaissance Technologies LLC now owns 1,737,734 shares of the technology company’s stock worth $5,317,000 after purchasing an additional 38,334 shares during the period. P.A.W. Capital Corp boosted its stake in Marchex by 8.3% in the 2nd quarter. P.A.W. Capital Corp now owns 1,300,000 shares of the technology company’s stock worth $3,978,000 after purchasing an additional 100,000 shares during the period. Unterberg Capital LLC boosted its stake in Marchex by 94.1% in the 2nd quarter. Unterberg Capital LLC now owns 970,526 shares of the technology company’s stock worth $2,970,000 after purchasing an additional 470,526 shares during the period. Finally, Ancora Advisors LLC boosted its stake in Marchex by 16.6% in the 1st quarter. Ancora Advisors LLC now owns 955,253 shares of the technology company’s stock worth $2,608,000 after purchasing an additional 136,272 shares during the period. Institutional investors and hedge funds own 50.54% of the company’s stock.

Marchex Company Profile

Marchex, Inc operates as a call analytics company. Its products include Marchex Call Analytics, an analytics technology platform that provides data and insights to measure the performance of mobile, online, and offline advertising for advertisers and small business resellers; and Marchex Speech Analytics delivers actionable operational and advertising insights of inbound calls from consumer's interactions.

Recommended Story: How to Use the New Google Finance Tool

Get a free copy of the Zacks research report on Marchex (MCHX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.